Same here. If we get the positive numbers we expect, even our hedgefund CEO can't screw it up. It would serve this company and all shareholders well if he would just announce the data and back off. Let the news itself work its own wonder on Wall Street. Let peer review journals, magazines, networks and brokerages (trough 'BUY" ratings) sing our song. Rabin has done enough damage to the "excitement" of these trials with his sideline shinanagins. He has found a way with his PERSONAL INTERESTS to harm this company in the eyes of potential investors. -- IT FOR THE SCIENCE NOT THE CEO!
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.